[Kallmann syndrome].
Sato
Naoko
N
Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development.
Ogata
Tsutomu
T
D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004967:Estrogens / Q000008:administration & dosage; D016326:Extracellular Matrix Proteins / Q000235:genetics; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D006801:Humans; D017436:Kallmann Syndrome / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008596:Menotropins / Q000008:administration & dosage; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000235:genetics; D011379:Prognosis; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics; D013739:Testosterone / Q000008:administration & dosage
C076266:ANOS1 protein, human; D006063:Chorionic Gonadotropin; D004967:Estrogens; D016326:Extracellular Matrix Proteins; D009419:Nerve Tissue Proteins; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D008596:Menotropins; C496348:FGFR1 protein, human; D051496:Receptor, Fibroblast Growth Factor, Type 1